Vigene’s COVID-19 Update – March 23rd, 2020

We would like to update you on the precautions and actions that Vigene Biosciences is taking due to the rapidly changing situation of the global Coronavirus pandemic (COVID-19).

The health and safety of our employees, customers, and visitors to our facilities is our top priority. We are actively working with our customers as well as our suppliers on how to best manage the current situation and mitigate risk for everyone. We have established an internal task force comprised of members of our Executive team, our Health and Safety experts and other relevant staff members.  This task force has established multiple policies to protect our employees’ health & safety while allowing us to continue working on your important projects. Non-Essential departments are also working remotely and/or working alternative hours to practice social distancing.

Currently, Research Grade productions, Plasmid productions (GMP-S and GMP) and GMP Viral Vector productions are still in regular operation.  Vigene Biosciences is closely following the COVID-19 situation. Maryland Governor Hogan has issued an order in the state of Maryland to require the closing of non-essential businesses effective 5:00 p.m. today March 23^rd 2020.  Vigene Biosciences is an essential business based on the public health mission we deliver to ensure the quality of medicines in the U.S. and around the world.  The operation will be following a social-distancing guideline.  There may be a delay for some production projects. You will be notified via email by our Customer Support team if there is a delay on your project.

Due to the closures of some organizations, we will request shipment approval from all customers prior to any orders being shipped. No order will be shipped without customer’s approval.

We hope everyone stays safe & healthy and should you have any questions, please feel free to contact us at custsupport@vigenebio.com.